The United States pharmaceutical 3PL market was valued at USD 59.15 Billion in 2025 and is expected to grow at a CAGR of 4.20%, reaching USD 89.25 Billion by 2035. The market growth is fueled by increasing outsourcing of logistics and supply chain operations by pharmaceutical companies.
Base Year
Historical Period
Forecast Period
A study published in February 2024 reported that approximately 129 million people in the US have at least one major chronic disease. Pharmaceutical 3PL guarantees secure and effective distribution of drugs, supporting market expansion.
The surge in the production of temperature-sensitive products such as vaccines, biologics, and specialty drugs is expected to boost the market demand for pharmaceutical 3PL.
The growing collaboration between pharmaceutical 3PL providers and pharmaceutical companies, technology providers is one of the major trends, likely to elevate the market value.
Compound Annual Growth Rate
4.2%
Value in USD Billion
2026-2035
*this image is indicative*
Pharmaceutical 3PL (or third-party logistics) consists of contracting out logistics and distribution tasks for pharmaceutical products to specialized providers. These providers oversee storage, shipping, stock control, wrapping, and order processing for secure and prompt delivery to different medical facilities and patients. Pharmaceutical 3PL services manage delicate products such as vaccines and specialty drugs in accordance with stringent regulatory requirements. There are three primary categories of pharmaceutical 3PL, namely, transportation-centered, warehouse/distribution-centric, and forwarder-centric, each providing various logistical solutions.
These services play a vital role in the pharmaceutical sector by ensuring efficient and safe product distribution, compliance with regulations, and enabling companies to concentrate on main tasks while cutting costs and improving supply chain management. Pharmaceutical 3PL providers oversee the distribution process by accepting products from manufacturers and storing them in warehouses with controlled temperatures. They are also responsible for managing reverse logistics and maintaining regulatory compliance across the supply chain.
These suppliers provide specific services such as serialization to combat counterfeiting and are essential allies for manufacturers in complying with intricate regulatory demands. They are crucial in managing sudden increases in demand, offering valuable insights using data analysis to improve inventory levels and increase operational efficiency.
Rising Prevalence of Chronic Diseases Drives Market Growth
The rising occurrence of long-term illnesses such as diabetes, heart disease, and cancer is driving the demand for pharmaceutical 3PL services. In February 2024, a study published by the US Department of Health and Human Services found that approximately 129 million people in the United States have at least one major chronic disease. Five of the top 10 leading causes of death in the country are preventable or treatable chronic diseases. There is an increasing number of patients who need long-term medication, leading to a need for efficient distribution. Dealing with chronic illnesses frequently requires specific medications, requiring intricate logistical solutions. Pharmaceutical third-party logistics (3PL) providers are prepared to meet these needs, guaranteeing secure and effective distribution of drugs to support market expansion.
Adoption of Cold Chain Logistics to Boost United States Pharmaceutical 3PL Market Demand
The need for cold chain logistics in the pharmaceutical industry is on the rise as more temperature-sensitive products such as vaccines, biologics, and specialty drugs are being produced. In early September 2024, UPS, a US-based company announced the acquisition of Frigo-Trans and BPL, which are leading healthcare logistics capabilities with cold-chain providers in Germany, to enhance their European capabilities for temperature-sensitive and time-critical logistics services for UPS Healthcare customers. The emergence of personalized medicine and biologics has raised the demand for more sophisticated cold chain solutions.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Market Breakup by Service Type
Market Breakup by Supply Chain
Market Breakup by End Use
Market Breakup by Region
Market Segmentation based on Supply Chain is Anticipated to Witness Substantial Growth
Based on the supply chain, the market is divided into cold chain and non-cold chain. Out of these, cold chain services are expected to dominate the market due to the increasing demand for temperature-sensitive products such as biologics, vaccines, and specialty drugs. Accurate temperature control is vital to ensure the effectiveness and safety of these products during shipping, highlighting the importance of cold chain logistics. The increasing popularity of biologics and personalized medicines is projected to increase the need for dependable cold chain services, leading to expansion in this segment of the 3PL industry.
The Southeast region holds the largest market share in the United States, owing to the dense population, robust healthcare infrastructure, and the presence of many pharmaceutical manufacturing and distribution centers. This area houses multiple healthcare facilities, research institutions, and specialty clinics, leading to a need for effective pharmaceutical logistics. Furthermore, its advanced transportation networks and strategic positioning also make it a perfect center for pharmaceutical distribution.
The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as strategic initiatives by the leading players. The major companies in the market are as follows:
Kerry Logistics is a listed company offering third-party logistics, freight, warehouse, and supply chain services. They prioritize the safe handling of pharmaceutical products and meet industry demands for transporting life-saving goods like vaccines and medical devices with strict safety standards, regulatory compliance, and end-to-end solutions for various industries.
UPS is a US-based shipping, and supply chain company founded in 1907 as American Messenger Company, headquartered in Atlanta. In early September 2024, UPS announced the acquisition of Frigo-Trans and BPL, leading healthcare logistics capabilities with cold-chain providers in Germany, to enhance their European capabilities for temperature-sensitive and time-critical logistics services for UPS Healthcare customers.
DHL is a global logistics company headquartered in Bonn, Germany, with United States based roots. They specialize in cold chain technologies for shipping pharmaceuticals , ensuring the right temperature for life-saving efficacy. DHL Medical Express offers a comprehensive cold chain logistics solution for sensitive medical products.
C.H. Robinson Worldwide is an American transportation company specializing in third-party logistics. They provide freight transportation, management, brokerage, and warehousing services through partnerships with motor carriers, railroads, and ocean/air carriers.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Service Type |
|
| Breakup by Supply Chain |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share